Results 161 to 170 of about 1,864,473 (295)

Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Noncommunicable diseases (NCDs) are multifactorial, long‐term, chronic conditions that represent a burden to health‐care systems worldwide as they can only be controlled rather than cured; hence, they require long‐term care. With the exponential increase in NCDs, the occurrence of individuals presenting with more than one chronic disease is ...
Crystal Marruganti   +2 more
wiley   +1 more source

Changes in Muscle Strength Following Semaglutide Treatment in Adults: A Systematic Review With Meta‐Analysis of Handgrip Strength

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To systematically review and quantitatively synthesize within‐group changes in skeletal muscle strength following semaglutide treatment in adults. Materials and Methods This PRISMA 2020 systematic review was registered in PROSPERO (CRD420251185935).
Luís Guilherme Machado   +9 more
wiley   +1 more source

Anticoagulation After Bariatric Surgery: Beyond Warfarin. [PDF]

open access: yesJ Brown Hosp Med
Walden D, Wang E, Dapaah-Afriyie K.
europepmc   +1 more source

Metabolic Bariatric Surgery Leads to Similar Benefits for Diabetes Management and Glycaemia in Remitters and Non‐Remitters

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Metabolic bariatric surgery (MBS), for example, Roux‐en‐Y gastric bypass (RYGB) can lead to diabetes remission. However, this crude dichotomous outcome fails to fully capture post‐operative improvements in glycaemia and reduced medication burden in people who do not remit.
Julia S. Kenkre   +26 more
wiley   +1 more source

Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?

open access: yes, 2015
Marco Raffaelli,1 Luca Sessa,1 Geltrude Mingrone,2 Rocco Bellantone1 1Division of Endocrine and Metabolic Surgery, 2Division of Obesity Diseases, Università Cattolica del Sacro Cuore, Rome, Italy Abstract: The worldwide prevalence of type 2 ...
Sessa L   +3 more
core  

Screening for Nutritional Risk in Adults Receiving Obesity Treatment: A Systematic Literature Review of Available Tools and Identification of Conceptual Gaps

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Identify nutrition screening tools used in obesity research and qualitatively assess their appropriateness for evaluating nutritional risk in adults receiving obesity treatment, including with obesity management medications (OMMs) in outpatient clinical settings.
Marian A. E. de van der Schueren   +7 more
wiley   +1 more source

The Impact of Hospital Volume on Bariatric Surgery Safety: A Population-Based Study using Data from the National Bariatric Surgery Registry of the United Kingdom. [PDF]

open access: yesObes Surg
Bobotis S   +10 more
europepmc   +1 more source

Cardiovascular Outcomes in Semaglutide Versus Tirzepatide Users With Obesity and Atherosclerotic Disease: A Target Trial Emulation

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Semaglutide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, is approved for cardiovascular risk reduction in individuals with overweight or obesity and cardiovascular disease. Whether tirzepatide, a dual GLP‐1 and glucose‐dependent insulinotropic polypeptide receptor agonist, has similar cardiovascular benefits remains unknown.
Gwen Aubrac   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy